Principais Publicações
- de Souza J. M., Ferreira-Vieira T. H., Maciel E. M. A., Silva N. C., Lima I. B. Q., Doria J. G., Olmo I. G., Ribeiro F. M. (2022) mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington’s disease phenotype. Scientific Reports, 12, 8982.
- Andrade T. A., Fahel J. S., de Souza J. M., Terra A. C., Souza D. G., Costa V. V., Teixeira M. M., Bloise E., Ribeiro F. M. (2022) Exposure to Zika Virus Results in sex-Specific Memory Deficits and Neurological Alterations in Adult Mice. ASN Neuro, 14, 175909142211212.
- Olmo I. G., Olmo R.P., Gonçalves A. N. A., Pires R. G. W., Marques J. T., Ribeiro F. M. (2021) High-Throughput Sequencing of BACHD Mice Reveals Upregulation of Neuroprotective miRNAs at the Pre-Symptomatic Stage of Huntington’s Disease. ASN Neuro, 13, 175909142110098.
- Jackman J. A., Costa V., Park S., Real A. L. C. V., Park J. H., Cardozo P. L., Ferhan A. R., Olmo I. G., Moreira T. P., Bambirra J., Queiroz V. F., Queiroz-Junior C. M., Foureaux G., Souza D. G., Ribeiro F. M., Yoon B. K., Wynendaele E., de Spiegeleer B., Teixeira M. M., and Cho N. (2018) Therapeutic Treatment of Zika Virus Infection Using a Brain-Penetrating 2 Antiviral Peptide. Nature Materials, 17, 971–977.
- Doria J. G., de Souza J. M., Silva F. R., Olmo I. G., Carvalho T. G., Alves-Silva J., Ferreira-Vieira T. H., Santos J. T., Xavier C. Q. S., Silva N. C., Maciel E. M. A., Conn P. J. and Ribeiro F. M. (2018) The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington’s disease. J. Neurochem., 147, 222-239.
- Olmo I. G., Carvalho T. G., Costa V. V., Alves-Silva J., Ferrari C. Z., Izidoro-Toledo T. C., Silva J. F., Teixeira A. L., Souza D. G., Marques J. T., Teixeira M. M., Vieira L. B., and Ribeiro F. M. (2017) Zika virus promotes neuronal cell death in a non-cell autonomous manner by triggering the release of neurotoxic factors. Frontiers in Immunology, 8, 1016.
- Silva F. R., Miranda A. S., Santos R. P. M., Olmo I. G., Zamponi G. W., Dobransky T., Cruz J. S., Vieira L. B., and Ribeiro F. M. (2017) N-type Ca2+ channels are affected by full-length mutant huntingtin expression in a mouse model of Huntington’s disease. Neurobiology of Aging, 55, 1-10.
- Ferreira-Vieira T. H., Guimaraes I. M., Silva F. R., and Ribeiro F. M. (2016) Alzheimer’s disease: Targeting the cholinergic system. Current Neuropharmacology, 14, 101-115.
- Doria J. G., de Souza J. M., Andrade J. N., Rodrigues H. A., Guimaraes I. M., Carvalho T. G., Guatimosim C., Dobransky T., and Ribeiro F. M. (2015) The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington’s disease. Neurobiology of Disease, 73, 163-173.
- Ribeiro F. M., Devries R. A., Hamilton A., Guimaraes I. M., Cregan S. P., Pires R. G. W., and Ferguson S. S. G. (2013) Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of huntington’s disease. Human Molecular Genetics, 23, 2030-2042.
- Doria J. G., Silva F. R., Souza J. M., Vieira L. B., Carvalho T. G., Reis H. J., Pereira G. S. Dobransky T., and Ribeiro F. M. (2013) Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington’s disease. British Journal of Pharm., 169, 909-921.
- Ribeiro F. M., Paquet M., Ferreira L. T., Cregan T., Cregan S., and Ferguson S. S. G. (2010) Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington’s disease. J. Neuroscience, 30, 316-24.